You are here

Article Text

Article menu
Download PDFPDF
DTB select
Safety update: hyoscine hydrobromide patches and serious anticholinergic adverse effects

Abstract

Overview of: Medicines and Healthcare products Regulatory Agency. Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Drug Safety Update 2023;16:1.

  • Drug-Related Side Effects and Adverse Reactions
  • Health Care Quality, Access, and Evaluation

https://doi.org/10.1136/dtb.2023.000042

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.